Evotec reports Q1 2024 results and provides corporate update

EQS-News: Evotec SE


/ Key word: Quarterly / Interim Statement





Evotec reports Q1 2024 results and provides corporate update






22.05.2024 / 07:00 CET/CEST



The issuer is...

Related Keywords

Austria , France , Hamburg , Germany , Corbion , Basse Normandie , Worth An Der Donau , Niederörreich , Mario Polywka , Gabriele Hansen , Christian Wojczewski , Volker Braun , Evotec Biologics , Hinnerk Rohwedder , Marcy Lyon , Head Of Global Corporate Communications , Crohn Colitis Foundation , Nasdaq , Health Ingredients , Crohn Colitis Foundation The , Global Corporate Communications , Variant Bio Inc , Evotec Biologics Inc , Novartis , Bristol Myers Squibb , Bioscience Laboratories Inc , Evotec Se Frankfurt Stock Exchange , Evotec Group , Linkedin , Frankfurt Stock Exchange , Colitis Foundation , Claris Ventures , Chief People Officer , Chief Executive Officer , Chief Financial Officer , Adjusted Group , Bristol Myers , Advanced Bioscience Laboratories , Clinical Trial Application , Variant Bio , Management Board , Supervisory Board , Evotec Gene Therapy , Global Investor Relations ,